Hotline: +86-18022463983    020-85206863

Global Quetiapine Fumarate Market Outlook 2022

Published Date: 2021-12-31   |   Pages: 119   |   Tables: 134   |  Pharma & Healthcare

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share. The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

The global Quetiapine Fumarate market was valued at US$ 163.3 million in 2020 and is expected to reach US$ 139.8 million by the end of 2027, growing at a CAGR of -2.2% during 2021-2027.

This report focuses on Quetiapine Fumarate volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Quetiapine Fumarate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Quetiapine Fumarate Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Immediate Release Tablets

Extended Release Tablets

Segment by Application

Adult

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

AstraZeneca

Intas

TAPI

Accord

Hexal

Dr.Reddy's

Lupin

Sun Pharmaceutical

Hunan Dongting Pharm

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Quetiapine Fumarate Market Overview

1.1 Product Overview and Scope of Quetiapine Fumarate

1.2 Quetiapine Fumarate Segment by Type

1.2.1 Global Quetiapine Fumarate Sales Growth Rate Comparison by Type (2021-2027)

1.2.2 Immediate Release Tablets

1.2.3 Extended Release Tablets

1.3 Quetiapine Fumarate Segment by Application

1.3.1 Global Quetiapine Fumarate Sales Comparison by Application: (2021-2027)

1.3.2 Adult

1.3.3 Others

1.4 Global Quetiapine Fumarate Market Size Estimates and Forecasts

1.4.1 Global Quetiapine Fumarate Revenue 2016-2027

1.4.2 Global Quetiapine Fumarate Sales 2016-2027

1.4.3 Quetiapine Fumarate Market Size by Region: 2016 Versus 2021 Versus 2027

2 Quetiapine Fumarate Market Competition by Manufacturers

2.1 Global Quetiapine Fumarate Sales Market Share by Manufacturers (2016-2021)

2.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Quetiapine Fumarate Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Quetiapine Fumarate Manufacturing Sites, Area Served, Product Type

2.5 Quetiapine Fumarate Market Competitive Situation and Trends

2.5.1 Quetiapine Fumarate Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Quetiapine Fumarate Players Market Share by Revenue

2.5.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Quetiapine Fumarate Retrospective Market Scenario by Region

3.1 Global Quetiapine Fumarate Retrospective Market Scenario in Sales by Region: 2016-2021

3.2 Global Quetiapine Fumarate Retrospective Market Scenario in Revenue by Region: 2016-2021

3.3 North America Quetiapine Fumarate Market Facts & Figures by Country

3.3.1 North America Quetiapine Fumarate Sales by Country

3.3.2 North America Quetiapine Fumarate Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Quetiapine Fumarate Market Facts & Figures by Country

3.4.1 Europe Quetiapine Fumarate Sales by Country

3.4.2 Europe Quetiapine Fumarate Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Region

3.5.1 Asia Pacific Quetiapine Fumarate Sales by Region

3.5.2 Asia Pacific Quetiapine Fumarate Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Quetiapine Fumarate Market Facts & Figures by Country

3.6.1 Latin America Quetiapine Fumarate Sales by Country

3.6.2 Latin America Quetiapine Fumarate Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country

3.7.1 Middle East and Africa Quetiapine Fumarate Sales by Country

3.7.2 Middle East and Africa Quetiapine Fumarate Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4 Global Quetiapine Fumarate Historic Market Analysis by Type

4.1 Global Quetiapine Fumarate Sales Market Share by Type (2016-2021)

4.2 Global Quetiapine Fumarate Revenue Market Share by Type (2016-2021)

4.3 Global Quetiapine Fumarate Price by Type (2016-2021)

5 Global Quetiapine Fumarate Historic Market Analysis by Application

5.1 Global Quetiapine Fumarate Sales Market Share by Application (2016-2021)

5.2 Global Quetiapine Fumarate Revenue Market Share by Application (2016-2021)

5.3 Global Quetiapine Fumarate Price by Application (2016-2021)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Corporation Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Intas

6.2.1 Intas Corporation Information

6.2.2 Intas Description and Business Overview

6.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.2.4 Intas Quetiapine Fumarate Product Portfolio

6.2.5 Intas Recent Developments/Updates

6.3 TAPI

6.3.1 TAPI Corporation Information

6.3.2 TAPI Description and Business Overview

6.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.3.4 TAPI Quetiapine Fumarate Product Portfolio

6.3.5 TAPI Recent Developments/Updates

6.4 Accord

6.4.1 Accord Corporation Information

6.4.2 Accord Description and Business Overview

6.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Accord Quetiapine Fumarate Product Portfolio

6.4.5 Accord Recent Developments/Updates

6.5 Hexal

6.5.1 Hexal Corporation Information

6.5.2 Hexal Description and Business Overview

6.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.5.4 Hexal Quetiapine Fumarate Product Portfolio

6.5.5 Hexal Recent Developments/Updates

6.6 Dr.Reddy's

6.6.1 Dr.Reddy's Corporation Information

6.6.2 Dr.Reddy's Description and Business Overview

6.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio

6.6.5 Dr.Reddy's Recent Developments/Updates

6.7 Lupin

6.6.1 Lupin Corporation Information

6.6.2 Lupin Description and Business Overview

6.6.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.4.4 Lupin Quetiapine Fumarate Product Portfolio

6.7.5 Lupin Recent Developments/Updates

6.8 Sun Pharmaceutical

6.8.1 Sun Pharmaceutical Corporation Information

6.8.2 Sun Pharmaceutical Description and Business Overview

6.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio

6.8.5 Sun Pharmaceutical Recent Developments/Updates

6.9 Hunan Dongting Pharm

6.9.1 Hunan Dongting Pharm Corporation Information

6.9.2 Hunan Dongting Pharm Description and Business Overview

6.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio

6.9.5 Hunan Dongting Pharm Recent Developments/Updates

6.10 SuZhou NO.4 Phamaceutical Factory

6.10.1 SuZhou NO.4 Phamaceutical Factory Corporation Information

6.10.2 SuZhou NO.4 Phamaceutical Factory Description and Business Overview

6.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio

6.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates

6.11 Fuan Pharmaceutical

6.11.1 Fuan Pharmaceutical Corporation Information

6.11.2 Fuan Pharmaceutical Quetiapine Fumarate Description and Business Overview

6.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio

6.11.5 Fuan Pharmaceutical Recent Developments/Updates

6.12 Zhejiang Supor Pharmaceuticals

6.12.1 Zhejiang Supor Pharmaceuticals Corporation Information

6.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Description and Business Overview

6.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio

6.12.5 Zhejiang Supor Pharmaceuticals Recent Developments/Updates

6.13 Zhejiang Huahai Pharmaceutical

6.13.1 Zhejiang Huahai Pharmaceutical Corporation Information

6.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Description and Business Overview

6.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)

6.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio

6.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

7 Quetiapine Fumarate Manufacturing Cost Analysis

7.1 Quetiapine Fumarate Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Quetiapine Fumarate

7.4 Quetiapine Fumarate Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Quetiapine Fumarate Distributors List

8.3 Quetiapine Fumarate Customers

9 Quetiapine Fumarate Market Dynamics

9.1 Quetiapine Fumarate Industry Trends

9.2 Quetiapine Fumarate Growth Drivers

9.3 Quetiapine Fumarate Market Challenges

9.4 Quetiapine Fumarate Market Restraints

10 Global Market Forecast

10.1 Quetiapine Fumarate Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Quetiapine Fumarate by Type (2022-2027)

10.1.2 Global Forecasted Revenue of Quetiapine Fumarate by Type (2022-2027)

10.2 Quetiapine Fumarate Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Quetiapine Fumarate by Application (2022-2027)

10.2.2 Global Forecasted Revenue of Quetiapine Fumarate by Application (2022-2027)

10.3 Quetiapine Fumarate Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Quetiapine Fumarate by Region (2022-2027)

10.3.2 Global Forecasted Revenue of Quetiapine Fumarate by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

Table 1. Global Quetiapine Fumarate Sales (MT) Growth Rate Comparison by Type (2021-2027)

Table 2. Global Quetiapine Fumarate Sales (MT) Comparison by Application (2021-2027)

Table 3. Global Quetiapine Fumarate Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)

Table 4. Key Manufacturers Quetiapine Fumarate Covered in This Study

Table 5. Global Quetiapine Fumarate Sales (MT) of Key Manufacturers (2016-2021)

Table 6. Global Quetiapine Fumarate Sales Market Share by Manufacturers (2016-2021)

Table 7. Global Quetiapine Fumarate Revenue (US$ Million) by Manufacturers (2016-2021)

Table 8. Global Quetiapine Fumarate Revenue Share by Manufacturers (2016-2021)

Table 9. Global Market Quetiapine Fumarate Average Price (USD/Kg) of Key Manufacturers (2016-2021)

Table 10. Manufacturers Quetiapine Fumarate Manufacturing Sites and Area Served

Table 11. Manufacturers Quetiapine Fumarate Product Type

Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Quetiapine Fumarate as of 2020)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Global Quetiapine Fumarate Sales by Region (2016-2021) & (MT)

Table 16. Global Quetiapine Fumarate Sales Market Share by Region (2016-2021)

Table 17. Global Quetiapine Fumarate Revenue by Region (2016-2021) & (US$ Million)

Table 18. North America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)

Table 19. North America Quetiapine Fumarate Sales Market Share by Country (2016-2021)

Table 20. North America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)

Table 21. North America Quetiapine Fumarate Revenue Market Share by Country (2016-2021)

Table 22. Europe Quetiapine Fumarate Sales by Country (2016-2021) & (MT)

Table 23. Europe Quetiapine Fumarate Sales Market Share by Country (2016-2021)

Table 24. Europe Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)

Table 25. Europe Quetiapine Fumarate Revenue Market Share by Country (2016-2021)

Table 26. Asia Pacific Quetiapine Fumarate Sales by Region (2016-2021) & (MT)

Table 27. Asia Pacific Quetiapine Fumarate Sales Market Share by Region (2016-2021)

Table 28. Asia Pacific Quetiapine Fumarate Revenue by Region (2016-2021) & (US$ Million)

Table 29. Asia Pacific Quetiapine Fumarate Revenue Market Share by Region (2016-2021)

Table 30. Latin America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)

Table 31. Latin America Quetiapine Fumarate Sales Market Share by Country (2016-2021)

Table 32. Latin America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)

Table 33. Latin America Quetiapine Fumarate Revenue Market Share by Country (2016-2021)

Table 34. Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2021) & (MT)

Table 35. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2016-2021)

Table 36. Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)

Table 37. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2016-2021)

Table 38. Global Quetiapine Fumarate Sales (MT) by Type (2016-2021)

Table 39. Global Quetiapine Fumarate Sales Market Share by Type (2016-2021)

Table 40. Global Quetiapine Fumarate Revenue (Million US$) by Type (2016-2021)

Table 41. Global Quetiapine Fumarate Revenue Share by Type (2016-2021)

Table 42. Global Quetiapine Fumarate Price (USD/Kg) by Type (2016-2021)

Table 43. Global Quetiapine Fumarate Sales (MT) by Application (2016-2021)

Table 44. Global Quetiapine Fumarate Sales Market Share by Application (2016-2021)

Table 45. Global Quetiapine Fumarate Revenue (Million US$) by Application (2016-2021)

Table 46. Global Quetiapine Fumarate Revenue Share by Application (2016-2021)

Table 47. Global Quetiapine Fumarate Price (USD/Kg) by Application (2016-2021)

Table 48. AstraZeneca Corporation Information

Table 49. AstraZeneca Description and Business Overview

Table 50. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 51. AstraZeneca Quetiapine Fumarate Product

Table 52. AstraZeneca Recent Developments/Updates

Table 53. Intas Corporation Information

Table 54. Intas Description and Business Overview

Table 55. Intas Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 56. Intas Quetiapine Fumarate Product

Table 57. Intas Recent Developments/Updates

Table 58. TAPI Corporation Information

Table 59. TAPI Description and Business Overview

Table 60. TAPI Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 61. TAPI Quetiapine Fumarate Product

Table 62. TAPI Recent Developments/Updates

Table 63. Accord Corporation Information

Table 64. Accord Description and Business Overview

Table 65. Accord Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 66. Accord Quetiapine Fumarate Product

Table 67. Accord Recent Developments/Updates

Table 68. Hexal Corporation Information

Table 69. Hexal Description and Business Overview

Table 70. Hexal Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 71. Hexal Quetiapine Fumarate Product

Table 72. Hexal Recent Developments/Updates

Table 73. Dr.Reddy's Corporation Information

Table 74. Dr.Reddy's Description and Business Overview

Table 75. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 76. Dr.Reddy's Quetiapine Fumarate Product

Table 77. Dr.Reddy's Recent Developments/Updates

Table 78. Lupin Corporation Information

Table 79. Lupin Description and Business Overview

Table 80. Lupin Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 81. Lupin Quetiapine Fumarate Product

Table 82. Lupin Recent Developments/Updates

Table 83. Sun Pharmaceutical Corporation Information

Table 84. Sun Pharmaceutical Description and Business Overview

Table 85. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 86. Sun Pharmaceutical Quetiapine Fumarate Product

Table 87. Sun Pharmaceutical Recent Developments/Updates

Table 88. Hunan Dongting Pharm Corporation Information

Table 89. Hunan Dongting Pharm Description and Business Overview

Table 90. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 91. Hunan Dongting Pharm Quetiapine Fumarate Product

Table 92. Hunan Dongting Pharm Recent Developments/Updates

Table 93. SuZhou NO.4 Phamaceutical Factory Corporation Information

Table 94. SuZhou NO.4 Phamaceutical Factory Description and Business Overview

Table 95. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 96. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product

Table 97. SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates

Table 98. Fuan Pharmaceutical Corporation Information

Table 99. Fuan Pharmaceutical Description and Business Overview

Table 100. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 101. Fuan Pharmaceutical Quetiapine Fumarate Product

Table 102. Fuan Pharmaceutical Recent Developments/Updates

Table 103. Zhejiang Supor Pharmaceuticals Corporation Information

Table 104. Zhejiang Supor Pharmaceuticals Description and Business Overview

Table 105. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 106. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product

Table 107. Zhejiang Supor Pharmaceuticals Recent Developments/Updates

Table 108. Zhejiang Huahai Pharmaceutical Corporation Information

Table 109. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 110. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)

Table 111. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product

Table 112. Zhejiang Huahai Pharmaceutical Recent Developments/Updates

Table 113. Production Base and Market Concentration Rate of Raw Material

Table 114. Key Suppliers of Raw Materials

Table 115. Quetiapine Fumarate Distributors List

Table 116. Quetiapine Fumarate Customers List

Table 117. Quetiapine Fumarate Market Trends

Table 118. Quetiapine Fumarate Growth Drivers

Table 119. Quetiapine Fumarate Market Challenges

Table 120. Quetiapine Fumarate Market Restraints

Table 121. Global Quetiapine Fumarate Sales Forecast by Type (2022-2027) & (MT)

Table 122. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2022-2027)

Table 123. Global Quetiapine Fumarate Revenue Forecast by Type (2022-2027) & (US$ Million)

Table 124. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2022-2027)

Table 125. Global Quetiapine Fumarate Sales Forecast by Application (2022-2027) & (MT)

Table 126. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2022-2027)

Table 127. Global Quetiapine Fumarate Revenue Forecast by Application (2022-2027) & (US$ Million)

Table 128. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2022-2027)

Table 129. Global Quetiapine Fumarate Sales Forecast by Region (2022-2027) & (MT)

Table 130. Global Quetiapine Fumarate Sales Market Share Forecast by Region (2022-2027)

Table 131. Global Quetiapine Fumarate Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 132. Global Quetiapine Fumarate Revenue Market Share Forecast by Region (2022-2027)

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Quetiapine Fumarate

Figure 2. Global Quetiapine Fumarate Market Share by Type in 2020 & 2027

Figure 3. Immediate Release Tablets Product Picture

Figure 4. Extended Release Tablets Product Picture

Figure 5. Global Quetiapine Fumarate Market Share by Application in 2020 & 2027

Figure 6. Adult

Figure 7. Others

Figure 8. Global Quetiapine Fumarate Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 9. Global Quetiapine Fumarate Market Size 2016-2027 (US$ Million)

Figure 10. Global Quetiapine Fumarate Sales 2016-2027 (MT)

Figure 11. Global Quetiapine Fumarate Market Size Market Share by Region: 2016 VS 20210 VS 2027

Figure 12. Quetiapine Fumarate Sales Share by Manufacturers in 2020

Figure 13. Global Quetiapine Fumarate Revenue Share by Manufacturers in 2020

Figure 14. The Global 5 and 10 Largest Quetiapine Fumarate Players: Market Share by Revenue in 2020

Figure 15. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021

Figure 16. Global Quetiapine Fumarate Sales Market Share by Region (2016-2021)

Figure 17. Global Quetiapine Fumarate Sales Market Share by Region in 2020

Figure 18. Global Quetiapine Fumarate Revenue Market Share by Region (2016-2021)

Figure 19. Global Quetiapine Fumarate Revenue Market Share by Region in 2020

Figure 20. U.S. Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 21. Canada Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 22. Germany Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 23. France Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 24. U.K. Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 25. Italy Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 26. Russia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 27. China Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 28. Japan Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 29. South Korea Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 30. India Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 31. Australia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 32. Taiwan Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 33. Indonesia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 34. Thailand Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 35. Malaysia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 36. Philippines Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 37. Vietnam Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 38. Mexico Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 39. Brazil Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 40. Argentina Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 41. Turkey Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 42. Saudi Arabia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 43. U.A.E Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)

Figure 44. Sales Market Share of Quetiapine Fumarate by Type (2016-2021)

Figure 45. Sales Market Share of Quetiapine Fumarate by Application (2016-2021)

Figure 46. Sales Market Share of Quetiapine Fumarate by Application in 2020

Figure 47. Revenue Share of Quetiapine Fumarate by Application (2016-2021)

Figure 48. Revenue Share of Quetiapine Fumarate by Application in 2020

Figure 49. Manufacturing Cost Structure of Quetiapine Fumarate

Figure 50. Manufacturing Process Analysis of Quetiapine Fumarate

Figure 51. Quetiapine Fumarate Industrial Chain Analysis

Figure 52. Channels of Distribution

Figure 53. Distributors Profiles

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

Our Clients